Glaxo Bipolar Drug May Be Tied to Defect
Seattle Post Intelligencer - WASHINGTON — Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to birth defects. Newly reported data suggest a connection between the drug Lamictal …